These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1537855)

  • 1. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain.
    Jackson DG; Buckley J; Bell JI
    J Biol Chem; 1992 Mar; 267(7):4732-9. PubMed ID: 1537855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.
    Screaton GR; Bell MV; Jackson DG; Cornelis FB; Gerth U; Bell JI
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12160-4. PubMed ID: 1465456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
    Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
    J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat.
    Screaton GR; Bell MV; Bell JI; Jackson DG
    J Biol Chem; 1993 Jun; 268(17):12235-8. PubMed ID: 8509359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complex CD44 transcriptional unit; alternative splicing of three internal exons generates the epithelial form of CD44.
    Cooper DL; Dougherty G; Harn HJ; Jackson S; Baptist EW; Byers J; Datta A; Phillips G; Isola NR
    Biochem Biophys Res Commun; 1992 Jan; 182(2):569-78. PubMed ID: 1734871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase.
    Tanabe KK; Nishi T; Saya H
    Mol Carcinog; 1993; 7(4):212-20. PubMed ID: 8352881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.
    Dougherty GJ; Landorp PM; Cooper DL; Humphries RK
    J Exp Med; 1991 Jul; 174(1):1-5. PubMed ID: 2056274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splicing choice from ten variant exons establishes CD44 variability.
    Tölg C; Hofmann M; Herrlich P; Ponta H
    Nucleic Acids Res; 1993 Mar; 21(5):1225-9. PubMed ID: 8464707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas.
    Jackson DG; Schenker T; Waibel R; Bell JI; Stahel RA
    Int J Cancer Suppl; 1994; 8():110-5. PubMed ID: 7515025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice.
    Hirano H; Screaton GR; Bell MV; Jackson DG; Bell JI; Hodes RJ
    Int Immunol; 1994 Jan; 6(1):49-59. PubMed ID: 7511928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.
    Hofmann M; Rudy W; Zöller M; Tölg C; Ponta H; Herrlich P; Günthert U
    Cancer Res; 1991 Oct; 51(19):5292-7. PubMed ID: 1717145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of CD44 alternative splicing variants in lung cancer].
    Ohgami A; Sugio K; Mitsudomi T; Tsuda T; Yasumoto K
    Nihon Rinsho; 1995 Jul; 53(7):1704-9. PubMed ID: 7630011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.
    He Q; Lesley J; Hyman R; Ishihara K; Kincade PW
    J Cell Biol; 1992 Dec; 119(6):1711-9. PubMed ID: 1469058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
    Fox SB; Fawcett J; Jackson DG; Collins I; Gatter KC; Harris AL; Gearing A; Simmons DL
    Cancer Res; 1994 Aug; 54(16):4539-46. PubMed ID: 7519124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD44 variant transcripts in dog lymphatic tissue.
    Milde KF; Alejandro R; Pastori RL
    Immunogenetics; 1994; 40(6):437-44. PubMed ID: 7525471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin.
    Salmi M; Grön-Virta K; Sointu P; Grenman R; Kalimo H; Jalkanen S
    J Cell Biol; 1993 Jul; 122(2):431-42. PubMed ID: 8320265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies.
    Salles G; Zain M; Jiang WM; Boussiotis VA; Shipp MA
    Blood; 1993 Dec; 82(12):3539-47. PubMed ID: 7505117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44: structure, function, and association with the malignant process.
    Naor D; Sionov RV; Ish-Shalom D
    Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A PCR-based method for the analysis of human CD44 splice products.
    van Weering DH; Baas PD; Bos JL
    PCR Methods Appl; 1993 Oct; 3(2):100-6. PubMed ID: 7505677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.